Current measures of adiposity have limitations. Artificial intelligence (AI) models may accurately and efficiently estimate body composition (BC) from routine imaging. To assess the association of AI-derived BC compartments from magnetic resonance imaging (MRI) with cardiometabolic outcomes. Prospective cohort study. UK Biobank (UKB) observational cohort study. 33 432 UKB participants with no history of diabetes, myocardial infarction, or ischemic stroke (mean age, 65.0 years [SD, 7.8]; mean body mass index [BMI], 25.8 kg/m² [SD, 4.2]; 52.8% female) who underwent whole-body MRI. An AI tool was applied to MRI to derive 3-dimensional (3D) BC measures, including subcutaneous adipose tissue (SAT), visceral adipose tissue (VAT), skeletal muscle (SM), and SM fat fraction (SMFF), and then calculate their relative distribution. Sex-stratified associations of these relative compartments with incident diabetes mellitus (DM) and major adverse cardiovascular events (MACE) were assessed using restricted cubic splines. Adipose tissue compartments and SMFF increased and SM decreased with age. After adjustment for age, smoking, and hypertension, greater adiposity and lower SM proportion were associated with higher incidence of DM and MACE after a median follow-up of 4.2 years in sex-stratified analyses; however, after additional adjustment for BMI and waist circumference (WC), only elevated VAT proportions and high SMFF (top fifth percentile in the cohort for each) were associated with increased risk for DM (respective adjusted hazard ratios [aHRs], 2.16 [95% CI, 1.59 to 2.94] and 1.27 [CI, 0.89 to 1.80] in females and 1.84 [CI, 1.48 to 2.27] and 1.84 [CI, 1.43 to 2.37] in males) and MACE (1.37 [CI, 1.00 to 1.88] and 1.72 [CI, 1.23 to 2.41] in females and 1.22 [CI, 0.99 to 1.50] and 1.25 [CI, 0.98 to 1.60] in males). In addition, in males only, those in the bottom fifth percentile of SM proportion had increased risk for DM (aHR for the bottom fifth percentile of the cohort, 1.96 [CI, 1.45 to 2.65]) and MACE (aHR, 1.55 [CI, 1.15 to 2.09]). Results may not be generalizable to non-Whites or people outside the United Kingdom. Artificial intelligence-derived BC proportions were strongly associated with cardiometabolic risk, but after BMI and WC were accounted for, only VAT proportion and SMFF (both sexes) and SM proportion (males only) added prognostic information. None.

Rheumatic heart disease (RHD) represents a significant global health challenge, disproportionately affecting over 40 million people in low- and middle-income countries. Early detection through color Doppler echocardiography is crucial for treating RHD, but it requires specialized physicians who are often scarce in resource-limited settings. To address this disparity, artificial intelligence (AI)-driven tools for RHD screening can provide scalable, autonomous solutions to improve access to critical healthcare services in underserved regions. This paper introduces RADAR (Rapid AI-Assisted Echocardiography Detection and Analysis of RHD), a novel and generalizable AI approach for end-to-end spatiotemporal analysis of color Doppler echocardiograms, aimed at detecting early RHD in resource-limited settings. RADAR identifies key imaging views and employs convolutional neural networks to analyze diagnostically relevant phases of the cardiac cycle. It also localizes essential anatomical regions and examines blood flow patterns. It then integrates all findings into a cohesive analytical framework. RADAR was trained and validated on 1,022 echocardiogram videos from 511 Ugandan children, acquired using standard portable ultrasound devices. An independent set of 318 cases, acquired using a handheld ultrasound device with diverse imaging characteristics, was also tested. On the validation set, RADAR outperformed existing methods, achieving an average accuracy of 0.92, sensitivity of 0.94, and specificity of 0.90. In independent testing, it maintained high, clinically acceptable performance, with an average accuracy of 0.79, sensitivity of 0.87, and specificity of 0.70. These results highlight RADAR's potential to improve RHD detection and promote health equity for vulnerable children by enhancing timely, accurate diagnoses in underserved regions.

To develop and evaluate the clinical feasibility of a dynamic computed tomography (CT) protocol for assessing patellofemoral (PF) and tibiofemoral (TF) kinematics before and after total knee arthroplasty (TKA), and to quantify postoperative kinematic changes in a pilot study. In this prospective single-centre study, patients with primary osteoarthritis scheduled for cemented TKA underwent dynamic CT scans preoperatively and at 1-year follow-up during active flexion-extension-flexion. Preoperatively, the femur, tibia and patella were segmented using a neural network. Postoperatively, computer-aided design (CAD) implant models were aligned to CT data to determine relative implant-bone orientation. Due to metal artefacts, preoperative patella meshes were manually aligned to postoperative scans by four raters, and averaged for analysis. Anatomical coordinate systems were applied to quantify patellar flexion, tilt, proximal tip rotation, mediolateral translation and femoral condyle anterior-posterior translation. Descriptive statistics were reported, and interoperator agreement for patellar registration was assessed using intraclass correlation coefficients (ICCs). Ten patients (mean age, 65 ± 8 years; 6 men) were analysed across a shared flexion range of 14°-55°. Postoperatively, the patella showed increased flexion (median difference: 0.9°-3.9°), medial proximal tip rotation (median difference: 1.5°-6.0°), lateral tilt (median difference: 2.7°-5.5°), and lateral shift (median difference: -1.5 to -2.8 mm). The medial and lateral femoral condyles translated 2-4 mm anterior-posteriorly during knee flexion. Interoperator agreement for patellar registration ranged from good to excellent across all parameters (ICC = 0.85-1.00). This pilot study demonstrates that dynamic CT enables in vivo assessment of PF and TF kinematics before and after TKA. The protocol quantified postoperative kinematic changes and demonstrated potential as research tool. Further automation is needed to investigate relationships between these kinematic patterns and patient outcomes in larger-scale studies. Level III.

We aim to develop an interactive segmentation model that can offer accuracy and reliability for the segmentation of the irregularly shaped spinal cord and canal in degenerative cervical myelopathy (DCM) through manual click and model refinement. A dataset of 1444 frames from 294 magnetic resonance imaging records of DCM patients was used and we developed two different segmentation models for comparison : auto-segmentation and interactive segmentation. The former was based on U-Net and utilized a pretrained ConvNeXT-tiny as its encoder. For the latter, we employed an interactive segmentation model structured by SimpleClick, a large model that utilizes a vision transformer as its backbone, together with simple fine-tuning. The segmentation performance of the two models were compared in terms of their Dice scores, mean intersection over union (mIoU), Average Precision and Hausdorff distance. The efficiency of the interactive segmentation model was evaluated by the number of clicks required to achieve a target mIoU. Our model achieved better scores across all four-evaluation metrics for segmentation accuracy, showing improvements of +6.4%, +1.8%, +3.7%, and -53.0% for canal segmentation, and +11.7%, +6.0%, +18.2%, and -70.9% for cord segmentation with 15 clicks, respectively. The required clicks for the interactive segmentation model to achieve a 90% mIoU for spinal canal with cord cases and 80% mIoU for spinal cord cases were 11.71 and 11.99, respectively. We found that the interactive segmentation model significantly outperformed the auto-segmentation model. By incorporating simple manual inputs, the interactive model effectively identified regions of interest, particularly in the complex and irregular shapes of the spinal cord, demonstrating both enhanced accuracy and adaptability.

Recent advancements in artificial intelligence (AI) and the vast data generated by modern clinical systems have driven the development of AI solutions in medical imaging, encompassing image reconstruction, segmentation, diagnosis, and treatment planning. Despite these successes and potential, many stakeholders worry about the risks and ethical implications of imaging AI, viewing it as complex, opaque, and challenging to understand, use, and trust in critical clinical applications. The FUTURE-AI guideline for trustworthy AI in healthcare was established based on six guiding principles: Fairness, Universality, Traceability, Usability, Robustness, and Explainability. Through international consensus, a set of recommendations was defined, covering the entire lifecycle of medical AI tools, from design, development, and validation to regulation, deployment, and monitoring. In this paper, we describe how these specific recommendations can be instantiated in the domain of medical imaging, providing an overview of current best practices along with guidelines and concrete metrics on how those recommendations could be met, offering a valuable resource to the international medical imaging community.

Deep learning has demonstrated remarkable efficacy in reconstructing low-count PET (Positron Emission Tomography) images, attracting considerable attention in the medical imaging community. However, most existing deep learning approaches have not fully exploited the unique physical characteristics of PET imaging in the design of fidelity and prior regularization terms, resulting in constrained model performance and interpretability. In light of these considerations, we introduce an unrolled deep network based on maximum likelihood estimation for the Poisson distribution and a Generalized domain transformation for Sparsity learning, dubbed GS-Net. To address this complex optimization challenge, we employ the Alternating Direction Method of Multipliers (ADMM) framework, integrating a modified Expectation Maximization (EM) approach to address the primary objective and utilize the shrinkage thresholding approach to optimize the L1 norm term. Additionally, within this unrolled deep network, all hyperparameters are adaptively adjusted through end-to-end learning to eliminate the need for manual parameter tuning. Through extensive experiments on simulated patient brain datasets and real patient whole-body clinical datasets with multiple count levels, our method has demonstrated advanced performance compared to traditional non-iterative and iterative reconstruction, deep learning-based direct reconstruction, and hybrid unrolled methods, as demonstrated by qualitative and quantitative evaluations.

Video capsule endoscopy (VCE) originally revolutionized gastrointestinal imaging by providing a noninvasive method for evaluating small bowel diseases. Recent technological innovations, including enhanced imaging systems, artificial intelligence (AI), and improved localization, have significantly improved VCE's diagnostic accuracy, efficiency, and clinical utility. This review aims to summarize and evaluate recent technological advances in VCE, focusing on system comparisons, image enhancement, localization technologies, and AI-assisted lesion detection.

Osteoporosis is an under-screened musculoskeletal disorder that results in diminished quality of life and significant burden to the healthcare system. We aimed to evaluate the ability of Rho, an artificial intelligence (AI) tool, to prospectively identify patients at-risk for low bone mineral density (BMD) from standard x-rays, its adoption rate by radiologists, and acceptance by primary care providers (PCPs). Patients ≥50 years were recruited when undergoing an x-ray of a Rho-eligible body part for any clinical indication. Questionnaires were completed at baseline and 6-month follow-up, and PCPs of "Rho-Positive" patients (those likely to have low BMD) were asked for feedback. Positive predictive value (PPV) was calculated in patients who returned within 6 months for a DXA. Of 1145 patients consented, 987 had x-rays screened by Rho, and 655 were flagged as Rho-Positive. Radiologists included this finding in 524 (80%) of reports. Of all Rho-Positive patients, 125 had a DXA within 6 months; Rho had a 74% PPV for DXA T-Score <-1. From 51 PCP responses, 78% found Rho beneficial. Of 389 patients with follow-up questionnaire data, a greater proportion of Rho-Positive versus -negative patients had discussed bone health with their PCP since study start (36% vs 18%, <i>P</i> < .001), or were newly diagnosed with osteoporosis (11% vs 5%; <i>P</i> = .03). By identifying patients at-risk of low BMD, with acceptability of reporting by radiologists and generally positive feedback from PCPs, Rho has the potential to improve low screening rates for osteoporosis by leveraging existing x-ray data.

Artificial intelligence (AI) has become increasingly integral to various aspects of breast cancer care, including screening, diagnosis, and treatment. This study aimed to critically examine the application of AI throughout the breast cancer care continuum to elucidate key research developments, emerging trends, and prevalent patterns. English articles and reviews published between 1988 and 2024 were retrieved from the Web of Science database, focusing on studies that applied AI in breast cancer research. Collaboration among countries was analyzed using co-authorship networks and co-occurrence mapping. Additionally, clustering analysis using Latent Dirichlet Allocation (LDA) was conducted for topic modeling, whereas linear regression was employed to assess trends in research outputs over time. A total of 8,711 publications were included in the analysis. The United States has led the research in applying AI to the breast cancer care continuum, followed by China and India. Recent publications have increasingly focused on the utilization of deep learning and machine learning (ML) algorithms for automated breast cancer detection in mammography and histopathology. Moreover, the integration of multi-omics data and molecular profiling with AI has emerged as a significant trend. However, research on the applications of robotic and ML technologies in surgical oncology and postoperative care remains limited. Overall, the volume of research addressing AI for early detection, diagnosis, and classification of breast cancer has markedly increased over the past five years. The rapid expansion of AI-related research on breast cancer underscores its potential impact. However, significant challenges remain. Ongoing rigorous investigations are essential to ensure that AI technologies yield evidence-based benefits across diverse patient populations, thereby avoiding the inadvertent exacerbation of existing healthcare disparities.

Given the high burden of hepatocellular carcinoma (HCC), risk stratification in patients with cirrhosis is critical but remains inadequate. In this study, we aimed to develop and validate an HCC prediction model by integrating radiomics and deep learning features from liver and spleen computed tomography (CT) images into the established age-male-ALBI-platelet (aMAP) clinical model. Patients were enrolled between 2018 and 2023 from a Chinese multicenter, prospective, observational cirrhosis cohort, all of whom underwent 3-phase contrast-enhanced abdominal CT scans at enrollment. The aMAP clinical score was calculated, and radiomic (PyRadiomics) and deep learning (ResNet-18) features were extracted from liver and spleen regions of interest. Feature selection was performed using the least absolute shrinkage and selection operator. Among 2,411 patients (median follow-up: 42.7 months [IQR: 32.9-54.1]), 118 developed HCC (three-year cumulative incidence: 3.59%). Chronic hepatitis B virus infection was the main etiology, accounting for 91.5% of cases. The aMAP-CT model, which incorporates CT signatures, significantly outperformed existing models (area under the receiver-operating characteristic curve: 0.809-0.869 in three cohorts). It stratified patients into high-risk (three-year HCC incidence: 26.3%) and low-risk (1.7%) groups. Stepwise application (aMAP → aMAP-CT) further refined stratification (three-year incidences: 1.8% [93.0% of the cohort] vs. 27.2% [7.0%]). The aMAP-CT model improves HCC risk prediction by integrating CT-based liver and spleen signatures, enabling precise identification of high-risk cirrhosis patients. This approach personalizes surveillance strategies, potentially facilitating earlier detection and improved outcomes.